Skip to main content

Clinical Trials Using Fluorine F 18 Fluorthanatrace

Review the clinical trials studying fluorine f 18 fluorthanatrace on this list and use the filters to refine the results by age and location. Some clinical trials are held at NCI-Designated Cancer Centers and may be supported by other organizations.

You can find more information about the types and phases of clinical trials and what to expect or use our Steps to Find a Clinical Trial.

Trials 1-7 of 7

PARP-1 Expression with 18F-FluorThanatrace PET/CT in Patients with Metastatic Prostate Cancer
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
18F-FluorThanatrace PET/CT for Detection of PARP-1 in Patients with Pheochromocytoma and Paraganglioma
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
A Radiotracer ([18F]FluorThanatrace) by PET/CT for the Imaging of Breast Cancer
Status: Active
Location: 3 locations
[18F]FTT Positron Emission Tomography for the Measurement of PARP Tumor Expression in Patients with Metastatic Breast Cancer
Status: Active
Location: Fred Hutch/University of Washington/Seattle Children's Cancer Consortium, Seattle, Washington
[18F]FTT Positron Emission Tomography/Computed Tomography for the Imaging of Pancreatic Neuroendocrine Tumors
Status: Active
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania
Fluorine F 18 Fluorthanatrace PET/CT for Imaging of Patients with Primary or Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
Status: Active
Location: M D Anderson Cancer Center, Houston, Texas
Fluorine F 18 Fluorthanatrace Biodistribution, Metabolism and Excretion Analysis in Patients with Ovarian, Fallopian Tube or Primary Peritoneal Cancer
Status: Temporarily Closed to Accrual
Location: University of Pennsylvania/Abramson Cancer Center, Philadelphia, Pennsylvania